Caixia Li Selected Research

N-glycolylneuraminyllactosylceramide (HD3)

1/2021	3,4-dihydroxyacetophenone inhibits hypoxia-associated human pulmonary artery smooth muscle cell proliferation by reducing Ca2+ influx.
9/2020	3,4-dihydroxyacetophenone inhibits hypoxia-associated human pulmonary artery smooth muscle cell proliferation by reducing Ca2+ influx.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Caixia Li Research Topics

Disease

22	Neoplasms (Cancer) 01/2022 - 02/2012
9	Inflammation (Inflammations) 06/2021 - 10/2014
9	Fibrosis (Cirrhosis) 01/2021 - 04/2011
6	Pain (Aches) 06/2022 - 01/2014
5	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2018
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2021 - 12/2017
4	Sepsis (Septicemia) 04/2022 - 01/2018
4	Disease Progression 01/2022 - 06/2006
4	Infections 12/2021 - 05/2010
4	Hemorrhage 07/2021 - 06/2011
4	Hypoxia (Hypoxemia) 01/2021 - 06/2008
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 01/2020
4	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 11/2017
4	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 10/2014
4	IGA Glomerulonephritis (IGA Nephropathy) 08/2011 - 06/2006
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 11/2015
3	Breast Neoplasms (Breast Cancer) 01/2022 - 08/2007
3	Thrombocytopenia (Thrombopenia) 12/2021 - 11/2018
3	Myocardial Infarction 07/2021 - 06/2020
3	Thrombosis (Thrombus) 07/2021 - 01/2016
3	Body Weight (Weight, Body) 02/2021 - 05/2018
3	Leukemia 01/2021 - 02/2014
2	Lymphoma (Lymphomas) 12/2022 - 01/2022
2	Acute Lung Injury 04/2022 - 01/2018
2	Type 2 Diabetes Mellitus (MODY) 02/2022 - 02/2021
2	Cytokine Release Syndrome 01/2022 - 01/2020
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 01/2020
2	Multiple Myeloma 01/2022 - 01/2021
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 01/2019
2	Parkinson Disease (Parkinson's Disease) 09/2021 - 01/2020
2	Stroke (Strokes) 07/2021 - 02/2021
2	Diarrhea 02/2021 - 01/2018
2	Obesity 02/2021 - 12/2013
2	Blister (Bulla) 01/2021 - 01/2018
2	Bullous Pemphigoid (Pemphigoid) 01/2021 - 01/2018
2	Philadelphia Chromosome 01/2020 - 02/2014
2	Mitochondrial Diseases (Mitochondrial Disease) 12/2019 - 11/2016
2	Pancreatic Neoplasms (Pancreatic Cancer) 10/2019 - 07/2019
2	Neoplasm Metastasis (Metastasis) 11/2018 - 01/2016
2	Pneumonia (Pneumonitis) 10/2018 - 05/2010
2	Neuromyelitis Optica (Devic's Disease) 01/2018 - 07/2015
2	Insulin Resistance 01/2017 - 11/2015
2	Lung Neoplasms (Lung Cancer) 01/2017 - 01/2014
2	Liver Neoplasms (Liver Cancer) 01/2016 - 02/2012
2	Hyperhomocysteinemia 06/2013 - 11/2011
2	Carcinogenesis 03/2013 - 01/2011
2	Respiratory Syncytial Virus Infections 04/2012 - 01/2011
1	Pelvic Pain 06/2022
1	Anxiety Disorders (Anxiety Disorder) 06/2022

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2007
6	Pharmaceutical PreparationsIBA 10/2021 - 02/2012
5	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2020
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2013
4	CytokinesIBA 05/2018 - 01/2011
3	RNA (Ribonucleic Acid)IBA 10/2020 - 01/2014
3	Protein Isoforms (Isoforms)IBA 08/2018 - 01/2015
3	Biological ProductsIBA 10/2014 - 08/2007
2	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 01/2022 - 03/2018
2	Interleukin-17 (Interleukin 17)IBA 01/2022 - 01/2019
2	EnzymesIBA 01/2022 - 11/2016
2	HydrogelsIBA 01/2022 - 01/2020
2	Fingolimod Hydrochloride (FTY720)FDA Link 10/2021 - 01/2019
2	Therapeutic UsesIBA 06/2021 - 05/2018
2	Hemoglobins (Hemoglobin)IBA 02/2021 - 06/2020
2	3,4-dihydroxyacetophenoneIBA 01/2021 - 09/2020
2	N-glycolylneuraminyllactosylceramide (HD3)IBA 01/2021 - 09/2020
2	AutoantibodiesIBA 01/2021 - 01/2018
2	Indicators and Reagents (Reagents)IBA 01/2021 - 05/2010
2	MicroRNAs (MicroRNA)IBA 10/2020 - 01/2015
2	CeramidesIBA 06/2020 - 11/2011
2	Tyrosine Kinase InhibitorsIBA 01/2020 - 02/2014
2	NF-kappa B (NF-kB)IBA 04/2019 - 01/2018
2	raltitrexed (D 1694)IBA 01/2019 - 11/2018
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019 - 11/2018
2	TransglutaminasesIBA 01/2019 - 11/2018
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 03/2013
2	ChemokinesIBA 01/2018 - 01/2011
2	ProteomeIBA 01/2018 - 01/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 06/2013
2	ErbB Receptors (EGF Receptor)IBA 10/2014 - 02/2012
2	Immunoglobulins (Immunoglobulin)IBA 01/2014 - 05/2010
2	Oxidoreductases (Dehydrogenase)IBA 06/2013 - 01/2011
2	DNA (Deoxyribonucleic Acid)IBA 08/2011 - 03/2008
1	Etoposide (VP 16)FDA LinkGeneric 12/2022
1	SemustineIBA 12/2022
1	Melphalan (Alkeran)FDA LinkGeneric 12/2022
1	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2022

Therapy/Procedure

16	Therapeutics 02/2022 - 10/2014
6	Hematopoietic Stem Cell Transplantation 01/2021 - 10/2013
4	Aftercare (After-Treatment) 06/2022 - 01/2018
4	Drug Therapy (Chemotherapy) 12/2021 - 07/2019
2	Stem Cell Transplantation 12/2022 - 01/2019
2	General Anesthesia 06/2021 - 10/2017
2	Anesthesia 06/2021 - 10/2017
2	Salvage Therapy 01/2020 - 12/2017
2	Punctures 10/2018 - 01/2018
2	Ligation 10/2018 - 01/2018
2	Nephrectomy 08/2011 - 04/2011
1	BEAM regimen 12/2022
1	Transurethral Resection of Prostate (TURP) 06/2022